Intralesional bleomycin for acquired immunodeficiency syndrome-associated cutaneous Kaposi's sarcoma

Arch Dermatol. 1995 Feb;131(2):228. doi: 10.1001/archderm.131.2.228b.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Adult
  • Bleomycin / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Sarcoma, Kaposi / drug therapy*
  • Sarcoma, Kaposi / etiology

Substances

  • Bleomycin